A feasibility study for quantitative assessment of cerebrovascular malformations using flutriciclamide ([18F]GE-180) PET/MRI

A feasibility study for quantitative assessment of cerebrovascular malformations using flutriciclamide ([18F]GE-180) PET/MRI

AimNeuroinflammation plays a key role in both the pathogenesis and the progression of cerebral cavernous malformations (CCM). Flutriciclamide ([18F]GE-180) is a translocator protein (TSPO) targeting positron emission tomography (PET) tracer, developed for imaging neuroinflammation. The objectives of...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính: Sally Ji Who Kim, Janine M. Lupo, Yicheng Chen, Miguel H. Pampaloni, Henry F. VanBrocklin, Jared Narvid, Helen Kim, Youngho Seo
Định dạng: Bài viết
Ngôn ngữ:English
Được phát hành: Frontiers Media S.A. 2023-04-01
Loạt:Frontiers in Medicine
Những chủ đề:
vascular malformation
CCM
PET/MRI
quantitative susceptibility mapping (QSM)
flutriciclamide
GE-180
Truy cập trực tuyến:https://www.frontiersin.org/articles/10.3389/fmed.2023.1091463/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2023.1091463/full

Những quyển sách tương tự